INDICATION AND USAGE FOR TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) TUDORZA PRESSAIR is a prescription medicine to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term (chronic) lung disease that includes chronic bronchitis, emphysema, or both.

Tudorza® Pressair® is an anticholinergic indicated for the maintenance treatment of patients with COPD. Learn how it works.

TUDORZA PRESSAIR should be used with caution in patients with narrow-angle glaucoma or prostatic hyperplasia or bladder-neck obstruction. Instruct patients to consult a physician immediately should any worsening of glaucoma or worsening of urinary retention develop

TUDORZA PRESSAIR is an anticholinergic indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Note: TUDORZA PRESSAIR is not indicated for the initial treatment of acute episodes of bronchospasm (i.e. rescue therapy). 1

• TUDORZA ® PRESSAIR® (aclidinium bromide inhalation powder) is a prescription medicine to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term (chronic) lung disease that includes chronic bronchitis, emphysema, or both.

Tudorza® Pressair® is an anticholinergic indicated for the maintenance treatment of patients with COPD. Learn how it works.

Tudorza® Pressair® is an anticholinergic indicated for the maintenance treatment of patients with COPD. Learn how it works.

TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) is indicated for the maintenance treatment of patients with COPD. TUDORZA PRESSAIR is not indicated for the initial treatment of acute episodes of bronchospasm (i.e. rescue therapy 1).

TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) is indicated for the maintenance treatment of patients with COPD. TUDORZA PRESSAIR is not indicated for the initial treatment of acute episodes of bronchospasm (i.e. rescue therapy). 1

Tudorza® Pressair® is an anticholinergic indicated for the maintenance treatment of patients with COPD. Learn how it works.